Henry S. Friedman

Dr. Friedman is world’s foremost expert in glioblastomas and Dep Director of Preston Robert Tisch Brain Tumor Ctr. He is involved in the treatment of over 900 glioblastoma patients per year. He was also instrumental in the FDA approval of Avastin which generated $56 Billion for Roche Pharma (2004-2017).